Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Webiom

Explore full profile

Innovative microbiome-derived health products with a focus on reliability, differentiation, and professionalism

South Korea
Valuation $50–100M Last recorded · 2022
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Webiom and the history behind them.

About Webiom

Webiom.kr specializes in developing and marketing microbiome-derived health products. The company focuses on creating innovative solutions that leverage the benefits of microbiomes to enhance health and wellness. Their product line includes high-purity supplements such as rTG DHA 900 and various Phytosome formulations, which are designed to offer superior bioavailability and efficacy. Webiom.kr serves health-conscious consumers and healthcare professionals who seek reliable and differentiated health products. Operating in the health and wellness market, the company employs a direct-to-consumer business model, selling its products through its website and other online platforms. Revenue is generated through the sale of these specialized health supplements, which are marketed for their high purity and effectiveness.

Source: Dealroom company data

At a glance

Status
Operational
Headquarters
South Korea
Open positions
None listed
Dealroom signal
20.7/100
Business model
Manufacturing
Links
Website

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VC✓Equity / VC Apr 2022 $13M $51M KoBioLabs ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Webiom website traffic

Latest recorded traffic for Webiom is 2.7K monthly website visits, up 8% over the last three months.

Latest monthly visits2.7K 3-month web change+8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • KoBioLabs
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇰🇷 South Korea HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Webiom on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Webiom’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.